These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 26114190)
1. Serum intestinal-fatty acid binding protein as a biomarker for refractory celiac disease. Gross S; Adriaanse MP; Nijeboer P; Tack GJ; van Hoogstraten IM; Bouma G; Mulder CJ; von Blomberg BM; Vreugdenhil AC; Bontkes HJ J Gastrointestin Liver Dis; 2015 Jun; 24(2):258-9. PubMed ID: 26114190 [No Abstract] [Full Text] [Related]
2. Additional value of serum I-FABP levels for evaluating celiac disease activity in children. Vreugdenhil AC; Wolters VM; Adriaanse MP; Van den Neucker AM; van Bijnen AA; Houwen R; Buurman WA Scand J Gastroenterol; 2011 Dec; 46(12):1435-41. PubMed ID: 22029621 [TBL] [Abstract][Full Text] [Related]
3. [Intestinal fatty acid binding protein: marker of enterocyte damage in acute and chronic gastroenterological diseases]. Kocsis D; Papp M; Tornai T; Tulassay Z; Herszényi L; Tóth M; Juhász M Orv Hetil; 2016 Jan; 157(2):59-64. PubMed ID: 26726140 [TBL] [Abstract][Full Text] [Related]
4. IgA anti-tissue transglutaminase antibodies, first line in the diagnosis of celiac disease. Samaşca G; Iancu M; Farcău D; Butnariu A; Pop T; Pîrvan A; Andreica M; Miu N; Cristea V; Dejica D Clin Lab; 2011; 57(9-10):695-701. PubMed ID: 22029184 [TBL] [Abstract][Full Text] [Related]
5. Intestinal-FABP and liver-FABP: Novel markers for severe abdominal injury. Relja B; Szermutzky M; Henrich D; Maier M; de Haan JJ; Lubbers T; Buurman WA; Marzi I Acad Emerg Med; 2010 Jul; 17(7):729-35. PubMed ID: 20653587 [TBL] [Abstract][Full Text] [Related]
6. Serum adipocyte fatty acid binding proteins and adiponectin in patients with coronary artery disease: the significance of A-FABP/adiponectin ratio. Jin J; Peng DQ; Yuan SG; Zhao SP; Ning XH; Wang SH; Li SL Clin Chim Acta; 2010 Nov; 411(21-22):1761-5. PubMed ID: 20688054 [TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of serum intestinal fatty acid-binding protein in full-term infants with necrotizing enterocolitis]. Huang-Fu CR; Li P; Tian YF Zhongguo Dang Dai Er Ke Za Zhi; 2014 Nov; 16(11):1125-8. PubMed ID: 25406557 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of quantitative heart-fatty acid binding protein assays compared with Cardiodetect(®) in the early detection of acute coronary syndrome. Charpentier S; Maupas-Schwalm F; Cournot M; Elbaz M; Ducassé JL; Bottela JM; Lauque D Arch Cardiovasc Dis; 2011 Oct; 104(10):524-9. PubMed ID: 22044705 [TBL] [Abstract][Full Text] [Related]
9. Plasma heart-type fatty acid binding protein level in acute ischemic stroke: comparative analysis with plasma S100B level for diagnosis of stroke and prediction of long-term clinical outcome. Park SY; Kim MH; Kim OJ; Ahn HJ; Song JY; Jeong JY; Oh SH Clin Neurol Neurosurg; 2013 Apr; 115(4):405-10. PubMed ID: 22766253 [TBL] [Abstract][Full Text] [Related]
10. Utilizing HDL levels to improve detection of celiac disease in patients with iron deficiency anemia. Abu Daya H; Lebwohl B; Smukalla S; Lewis SK; Green PH Am J Gastroenterol; 2014 May; 109(5):769-70. PubMed ID: 24797006 [No Abstract] [Full Text] [Related]
11. [The value of serum intestinal fatty acid binding protein measurement in discriminating intestinal ischemia in patients with acute abdomen]. Shi H; Wu BY; Liu WH; Su BB; Li TT Zhonghua Nei Ke Za Zhi; 2012 Sep; 51(9):690-3. PubMed ID: 23158918 [TBL] [Abstract][Full Text] [Related]
12. Urinary levels of regenerating protein Iα do not differentiate celiac patients and healthy subjects. Ruíz-Ortiz E; Santos AL; Pujol-Autonell I; Planas R; Montraveta M; Pintos G; Doladé M; Cabré E; Vives-Pi M Biomarkers; 2013 Mar; 18(2):178-80. PubMed ID: 23312007 [TBL] [Abstract][Full Text] [Related]
13. Magneto immunofluorescence assay for diagnosis of celiac disease. Kergaravat SV; Beltramino L; Garnero N; Trotta L; Wagener M; Fabiano SN; Pividori MI; Hernandez SR Anal Chim Acta; 2013 Oct; 798():89-96. PubMed ID: 24070488 [TBL] [Abstract][Full Text] [Related]
14. Circulating FABP4 is a prognostic biomarker in patients with acute coronary syndrome but not in asymptomatic individuals. Reiser H; Klingenberg R; Hof D; Cooksley-Decasper S; Fuchs N; Akhmedov A; Zoller S; Marques-Vidal P; Marti Soler H; Heg D; Landmesser U; Rodondi N; Mach F; Windecker S; Vollenweider P; Matter CM; Lüscher TF; von Eckardstein A; Gawinecka J Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1872-9. PubMed ID: 26069234 [TBL] [Abstract][Full Text] [Related]
15. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure. Sun YP; Wei CP; Ma SC; Zhang YF; Qiao LY; Li DH; Shan RB J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865 [TBL] [Abstract][Full Text] [Related]
17. Comparison of assays for anti-endomysial and anti-transglutaminase antibodies for diagnosis of pediatric celiac disease. Levine A; Bujanover Y; Reif S; Gass S; Vardinon N; Reifen R; Lehmann D Isr Med Assoc J; 2000 Feb; 2(2):122-5. PubMed ID: 10804933 [TBL] [Abstract][Full Text] [Related]
18. A pilot study on the noninvasive evaluation of intestinal damage in celiac disease using I-FABP and L-FABP. Derikx JP; Vreugdenhil AC; Van den Neucker AM; Grootjans J; van Bijnen AA; Damoiseaux JG; van Heurn LW; Heineman E; Buurman WA J Clin Gastroenterol; 2009 Sep; 43(8):727-33. PubMed ID: 19359998 [TBL] [Abstract][Full Text] [Related]
19. [Predictive value of serological tests in the diagnosis of celiac disease]. Carroccio A; Di Prima L; Falci C; Le Moli C; Soresi M; Montalto G; Notarbartolo A Ann Ital Med Int; 2002; 17(2):102-7. PubMed ID: 12150043 [TBL] [Abstract][Full Text] [Related]
20. [Heart-type fatty acid-binding protein detection for early diagnosis of acute coronary syndrome]. Zhang P; Wang Q; Zheng L; Zeng FY; Qiu YR Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):358-60. PubMed ID: 16546748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]